| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/11/2010 | WO2010015205A1 The use of sophoricoside in preparing medicaments |
| 02/11/2010 | WO2009141532A3 Derivatives of 1,5-diphenyl pyrrole-3-carboxamide, preparation thereof and use of same as cannabinoid cb1 receptor antagonists |
| 02/11/2010 | WO2008142550A9 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors |
| 02/11/2010 | US20100036132 Process for the preparation of opiod modulators |
| 02/11/2010 | US20100035992 Methods and Compositions for Treating Inflammation and Inflammation-Related Pathologies |
| 02/11/2010 | US20100035967 Modulation of toll-like receptor 9 expression by antisense oligonucleotides |
| 02/11/2010 | US20100035943 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 02/11/2010 | US20100035937 Solubilized non-steroidal anti-inflammatory drugs |
| 02/11/2010 | US20100035936 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands |
| 02/11/2010 | US20100035926 Pyrazole derivatives as non-steroidal glucocorticoid receptor ligands |
| 02/11/2010 | US20100035923 Vr1 vanilloid receptor antagonists with a iononic substructure |
| 02/11/2010 | US20100035916 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
| 02/11/2010 | US20100035908 Substituted acetophenones useful as pde4 inhibitors |
| 02/11/2010 | US20100035903 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases |
| 02/11/2010 | US20100035893 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/11/2010 | US20100035880 Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as vr1 receptor antagonists |
| 02/11/2010 | US20100035875 Triazolopyridine jak inhibitor compounds and methods |
| 02/11/2010 | US20100035849 Novel methylenedioxy phenolic compounds and their use to treat disease |
| 02/11/2010 | US20100035848 Therapy for disorders of the proximal digestive tract |
| 02/11/2010 | US20100035842 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 02/11/2010 | US20100035841 Inhibitors of tyrosine kinases and uses thereof |
| 02/11/2010 | US20100035816 Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency or oxidative stress or skin ageing or dry skin |
| 02/11/2010 | US20100034890 Combinations of formoterol and fluticasone propionate for asthma |
| 02/11/2010 | US20100034853 Compositions of activated botulinum toxin type B |
| 02/11/2010 | CA2733499A1 Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 02/11/2010 | CA2733430A1 Novel methylenedioxy phenolic compounds and their use to treat disease |
| 02/11/2010 | CA2732932A1 Organic compounds |
| 02/11/2010 | CA2732908A1 Uses of mesenchymal stem cells |
| 02/11/2010 | CA2732850A1 Pharmaceutical uses of lanosta-8,24-dien-3-ols |
| 02/11/2010 | CA2732828A1 Novel phenylamino isonicotinamide compounds |
| 02/11/2010 | CA2732797A1 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) |
| 02/10/2010 | EP2151436A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity |
| 02/10/2010 | EP2151434A1 Alkoxypyrazoles and the process for their preparation |
| 02/10/2010 | EP2151433A1 Alkoxypyrazoles and the process for their preparation |
| 02/10/2010 | EP2150535A2 Pyrazole derivatives as p2x7 modulators |
| 02/10/2010 | EP2150263A1 Plant extract and its therapeutic use |
| 02/10/2010 | EP1699800B1 Bicyclic heterocyclic p-38 kinase inhibitors |
| 02/10/2010 | EP1525191B1 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 02/10/2010 | EP1490365B1 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 02/10/2010 | EP1354896B1 Monoclonal antibody directed against the human bst2 antigen |
| 02/10/2010 | CN100588647C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/10/2010 | CN100588395C Analgesic and anti-inflammatory compositions containing cox-2 inhibitors |
| 02/09/2010 | US7659407 Pharmaceutical compounds |
| 02/09/2010 | US7659385 Polynucleotides encoding molecules designated LDCAM |
| 02/09/2010 | US7659375 Interleukin specific immunoglobulin for prevention and treatment of vision, autoimmune, inflammatory and diabetic disorders |
| 02/09/2010 | US7659303 Reduce tumor necrosis factor; phosphodiesterase inhibitor; antiinflammatory agents; anticancer agents; antidepressants; skin diosrders |
| 02/09/2010 | US7659302 Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione |
| 02/09/2010 | US7659272 N-[phenyl or heteroaryl carbonoyl pyridyl] arylsulfonamides; antiinflammatory, antianaphylactic agents; transplant rejection, gastointestinal, respriatory system and skin disorders |
| 02/09/2010 | US7659267 2-(3-cyanophenyl)-4H-1,3-benzothiazin-4-one; cardiovascular, bone or joint diseases, infectious, inflammatory, kidney diseases; safe and good effects of cell death inhibition, Migration Inhibitory Factor (MIF) binding |
| 02/09/2010 | CA2484954C 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 02/09/2010 | CA2451562C Piperazine compound |
| 02/09/2010 | CA2451240C Cyclic diamine compound with 6 membered ring groups |
| 02/09/2010 | CA2440760C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 02/09/2010 | CA2439593C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 02/09/2010 | CA2438704C Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 02/09/2010 | CA2418224C Pharmaceutical composition |
| 02/09/2010 | CA2413061C Serine protease inhibitors |
| 02/09/2010 | CA2378976C Method of controlling body temperature while reducing shivering |
| 02/09/2010 | CA2349715C Electrotransport device including a compatible antimicrobial agent |
| 02/09/2010 | CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 02/04/2010 | WO2010013815A1 Composition for inhibiting expression of target gene |
| 02/04/2010 | WO2010013805A1 Aminopropylidene derivative |
| 02/04/2010 | WO2010013551A1 Preparation for oral administration comprising water-extracted chondroitin sulfate and quercetin glycoside |
| 02/04/2010 | WO2010013498A1 Therapeutic agent or preventive agent for osteoarthritis |
| 02/04/2010 | WO2010013494A1 Pharmaceutical composition comprising botulinum neurotoxin preparation incapable of being synaptically transported, and use thereof |
| 02/04/2010 | WO2010013279A2 Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug |
| 02/04/2010 | WO2010013158A1 Phenanthrenone compounds, compositions and methods |
| 02/04/2010 | WO2010013143A2 Methods for inhibiting mast cell activation and treating mast cell-dependent inflammatory diseases and disorders using lactobacillus |
| 02/04/2010 | WO2010013086A1 Phosphorylated dendrimers as antiinflammatory drugs |
| 02/04/2010 | WO2010012964A2 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/04/2010 | WO2010012619A1 Diazepan and piperazine derivatives modulators of chemokine receptors |
| 02/04/2010 | WO2010012438A2 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 02/04/2010 | WO2010012399A1 Indolylamides as modulators of the ep<sb>2</sb> receptor |
| 02/04/2010 | WO2010012396A1 5,6 substituted benzamide derivatives as modulators of the ep<sb>2 </sb>receptor |
| 02/04/2010 | WO2010012043A1 Methods and compositions |
| 02/04/2010 | WO2010012037A1 6-substituted isoflavonoid compounds and uses thereof |
| 02/04/2010 | WO2009129511A4 Fluocinolone formulations in a biodegradable polymer carrier |
| 02/04/2010 | WO2009068649A3 Antigen-binding constructs |
| 02/04/2010 | US20100029769 N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate, sodium lauryl sulfoacetate as penetration enhancers incorporated in a topical formulation to facilitate administration of diclofenac for topical or transdermal therapy or cosmetic use |
| 02/04/2010 | US20100029767 Anthranilic acid derivatives |
| 02/04/2010 | US20100029754 Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 |
| 02/04/2010 | US20100029728 Phosphodiesterase inhibitors |
| 02/04/2010 | US20100029720 Carboxamide Derivatives As Muscarinic Receptor Antagonists |
| 02/04/2010 | US20100029719 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 02/04/2010 | US20100029705 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis |
| 02/04/2010 | US20100029704 Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof |
| 02/04/2010 | US20100029699 Matrix metalloproteinase inhibitors |
| 02/04/2010 | US20100029693 Novel pi3k delta inhibitors and methods of use thereof |
| 02/04/2010 | US20100029689 Phosphodiesterase 4 inhibitors |
| 02/04/2010 | US20100029681 Heterocyclic compounds as calcium channel blockers |
| 02/04/2010 | US20100029675 Pyrimidine-2, 4-diamine JAK2 Kinase inhibiting anti-inflammation use |
| 02/04/2010 | US20100029657 Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof |
| 02/04/2010 | US20100029649 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors |
| 02/04/2010 | US20100029645 Inhibitors of Cytosolic Phospholipase A2 |
| 02/04/2010 | US20100029639 Ion channel modulating compounds and uses thereof |
| 02/04/2010 | US20100029636 Lck inhibitors |
| 02/04/2010 | US20100029631 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 02/04/2010 | US20100029627 Mtki quinazoline derivatives |
| 02/04/2010 | US20100029599 Indolylamides as modulators of the EP2 receptor |
| 02/04/2010 | US20100029551 Treatment Of Inflammatory Lung Conditions With Aerosolized Macrolide Antibiotics |